CRITEO S.A. (CRTO) Spending and interest coverage
- R&D / revenue · 12 months: Value 15.27%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.74%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 15.27% | Research and development expense / revenue. Period ending 2026-06-30. $284.57M ÷ $1.86B × 100 ≈ 15.27% |
| Stock-based compensation / revenue · 12 months | 2.74% | Share-based compensation / revenue. Period ending 2026-06-30. $51.04M ÷ $1.86B × 100 ≈ 2.74% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 284.57M USD | Research and Development Expense |
| Revenue | 1.86B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 51.04M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 149.55M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $284.57M | $1.86B | $51.04M | $149.55M | (m) | 15.27% | 2.74% | (m) | (m) |
| 2026-03-31 | $292.24M | $1.92B | $55.79M | $165.00M | (m) | 15.24% | 2.91% | (m) | (m) |
| 2025-12-31 | $283.30M | $1.94B | $57.85M | $202.76M | (m) | 14.57% | 2.97% | (m) | (m) |
| 2025-06-30 | $293.20M | $1.95B | $95.83M | $182.73M | (m) | 15.07% | 4.92% | (m) | (m) |
| 2025-03-31 | $273.23M | $1.93B | $96.46M | $189.22M | (m) | 14.12% | 4.99% | (m) | (m) |
| 2024-12-31 | $279.34M | $1.93B | $106.61M | $151.40M | (m) | 14.45% | 5.51% | (m) | (m) |
| 2024-09-30 | $260.18M | $1.95B | $103.03M | $145.21M | (m) | 13.37% | 5.29% | (m) | (m) |
| 2024-06-30 | $237.42M | $1.96B | $92.82M | $147.04M | (m) | 12.13% | 4.74% | (m) | (m) |
| 2024-03-31 | $245.56M | $1.95B | $99.31M | $111.06M | $2.18M | 12.56% | 5.08% | 50.92× | Reported |
| 2023-12-31 | $242.29M | $1.95B | $97.19M | $77.22M | $2.24M | 12.43% | 4.99% | 34.41× | Reported |
| 2023-09-30 | $263.24M | $1.95B | $98.79M | $37.54M | $2.13M | 13.52% | 5.07% | 17.59× | Reported |
| 2023-06-30 | $243.44M | $1.93B | $95.86M | $30.59M | $2.12M | 12.64% | 4.98% | 14.44× | Reported |
| 2023-03-31 | $217.16M | $1.95B | $80.71M | $-26.88M | $1.96M | 11.13% | 4.14% | -13.68× | Reported |
| 2022-12-31 | $187.60M | $2.02B | $65.03M | $24.28M | $2.02M | 9.30% | 3.22% | 11.99× | Reported |
| 2022-09-30 | $163.11M | $2.11B | $54.95M | $41.38M | $2.17M | 7.75% | 2.61% | 19.06× | Reported |
| 2022-06-30 | $153.73M | $2.17B | $47.15M | $69.08M | $2.19M | 7.09% | 2.18% | 31.49× | Reported |
| 2022-03-31 | $154.15M | $2.22B | $46.80M | $145.32M | $2.28M | 6.93% | 2.10% | 63.79× | Reported |
| 2021-12-31 | $151.82M | $2.25B | $44.53M | $151.88M | $2.27M | 6.73% | 1.98% | 66.88× | Reported |
| 2021-09-30 | $139.75M | $2.26B | $38.48M | $153.32M | $2.38M | 6.18% | 1.70% | 64.36× | Reported |
| 2021-06-30 | $137.36M | $2.22B | $31.99M | $129.18M | $2.61M | 6.18% | 1.44% | 49.42× | Reported |
| 2021-03-31 | $126.69M | $2.11B | $27.48M | $119.24M | $2.92M | 6.00% | 1.30% | 40.85× | Reported |
| 2020-12-31 | $132.51M | $2.07B | $28.77M | $108.83M | $2.81M | 6.39% | 1.39% | 38.71× | Reported |
| 2020-09-30 | $140.30M | $2.06B | $26.70M | $100.52M | $2.85M | 6.80% | 1.29% | 35.33× | Reported |
| 2020-06-30 | $150.76M | $2.12B | $31.07M | $121.84M | $2.62M | 7.12% | 1.47% | 46.47× | Reported |
| 2020-03-31 | $163.53M | $2.21B | $35.62M | $131.62M | $2.29M | 7.41% | 1.61% | 57.43× | Reported |
| 2019-12-31 | $172.59M | $2.26B | $41.00M | $141.21M | $2.38M | 7.63% | 1.81% | 59.26× | Reported |
| 2019-09-30 | $176.61M | $2.28B | $47.03M | $144.52M | $2.00M | 7.75% | 2.06% | 72.26× | Reported |
| 2019-06-30 | $176.99M | $2.29B | $53.13M | $140.92M | $2.07M | 7.75% | 2.32% | 68.18× | Reported |
| 2019-03-31 | $180.52M | $2.29B | $61.65M | $145.70M | $2.07M | 7.87% | 2.69% | 70.25× | Reported |
| 2018-12-31 | $179.26M | $2.30B | $66.60M | $147.11M | $2.11M | 7.79% | 2.90% | 69.82× | Reported |
| 2018-09-30 | $181.59M | $2.30B | $76.06M | $155.44M | $2.18M | 7.88% | 3.30% | 71.34× | Reported |
| 2018-06-30 | $183.66M | $2.34B | $80.82M | $162.68M | $2.49M | 7.85% | 3.45% | 65.39× | Reported |
| 2018-03-31 | $179.72M | $2.34B | $75.50M | $151.59M | $2.65M | 7.67% | 3.22% | 57.10× | Reported |
| 2017-12-31 | $173.93M | $2.30B | $71.61M | $137.84M | $2.86M | 7.57% | 3.12% | 48.26× | Reported |
| 2017-09-30 | $162.54M | $2.19B | $65.12M | $119.79M | $2.97M | 7.42% | 2.97% | 40.39× | Reported |
| 2017-06-30 | $149.38M | $2.05B | $57.05M | $109.65M | $2.69M | 7.29% | 2.78% | 40.75× | Reported |
| 2017-03-31 | $136.01M | $1.91B | $49.83M | $114.27M | $2.65M | 7.10% | 2.60% | 43.15× | Reported |
| 2016-12-31 | $123.65M | $1.80B | $43.26M | $121.00M | $2.37M | 6.87% | 2.40% | 51.12× | Reported |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $86.81M | $1.32B | $23.99M | $76.33M | $653.00K | 6.56% | 1.81% | 116.90× | Reported |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $60.08M | $988.25M | $19.60M | $53.08M | $583.00K | 6.08% | 1.98% | 91.05× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Groupon, Inc. (GRPN) | United States | $0.850B | -7.77 |
| Stran & Company, Inc. (SWAG) | United States | $0.028B | 742.26 |
| Stagwell Inc (STGW) | $2.030B | 113.67 | |
| OMNICOM GROUP INC. (OMC) | United States | $21.279B | 371.02 |